Thrombolytics for acute ischemic stroke: Difference between revisions

No edit summary
Line 1: Line 1:
== Background ==
== Background ==


#Pros:
#Pros:  
##30% greater chance of good neurologic outcome at 3 months
##30% greater chance of good neurologic outcome at 3 months  
##Comparable 3-month mortality rate
##Comparable 3-month mortality rate  
#Cons
#Cons  
##Intracranial hemorrhage occurs in ~5% of pts
##Intracranial hemorrhage occurs in ~5% of pts


<br>


 
*Coag results prior to tx is only required for pts on anticoagulants  
*Coag results prior to tx is only required for pts on anticoagulants
*...but if history unable to be obtained must wait for coag results prior to starting tx
*...but if history unable to be obtained must wait for coag results prior to starting tx


== Inclusion Criteria ==
== Inclusion Criteria ==


#Diagnosis of ischemic stroke causing measurable neuro deficit
#Diagnosis of ischemic stroke causing measurable neuro deficit  
#Clear onset (last witnessed well) <3 hours (see below for extension to <4.5 hours)
#Clear onset (last witnessed well) &lt;3 hours (see below for extension to &lt;4.5 hours)  
#Age >18 yrs
#Age <u>&gt;</u>18 yrs


== Exclusion Criteria ==
== Exclusion Criteria ==


=== Absolute ===
=== Absolute ===


#Head trauma or prior stroke in previous 3 months
#Head trauma or prior stroke in previous 3 months  
#Symptoms suggestive of SAH
#Symptoms suggestive of SAH  
#Arterial puncture at noncompressible site in previous 7 days
#Arterial puncture at noncompressible site in previous 7 days  
#History of previous ICH
#History of previous ICH  
#Elevated BP (sys > 185 or dia > 110
#Elevated BP (sys &gt; 185 or dia &gt; 110)
#Active bleeding on exam
#Active bleeding on exam  
#Acute bleeding diathesis:
#Acute bleeding diathesis:  
##Plt count < 100K
##Plt count &lt; 100K&nbsp;
##PTT > upper limit of normal
##PTT &gt; upper limit of normal  
##INR >1.7
##INR &gt;1.7 or PT&gt;15 sec
#Blood Glucose <50
#Blood Glucose &lt;50  
#CT demonstrates multilobar infarction (hypodensity > 1/3 cerebral hemisphere)
#CT demonstrates multilobar infarction (hypodensity &gt; 1/3 cerebral hemisphere)


=== Relative ===
=== Relative ===


#Minor stroke or rapidly improving stroke symptoms
#Minor stroke or rapidly improving stroke symptoms  
#Seizure at onset with postictal residual neuro impairments
#Seizure at onset with postictal residual neuro impairments  
#Major surgery or serious trauma within previous 14 days
#Major surgery or serious trauma within previous 14 days  
#Acute GI or GU hemorrhage (within previous 21 days)
#Acute GI or GU hemorrhage (within previous 21 days)  
#Acute MI (within previous 3 months)
#Acute MI (within previous 3 months)


=== ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours) ===
=== ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours) ===


#Age > 80
All the above absolute exclusion criteria apply, but now with the additional exclusion criteria below
#Baseline NIHSS > 25
 
#Any oral anticoagulant use
#Age &gt; 80  
#Baseline NIHSS &gt; 25  
#Any oral anticoagulant use regardless of INR
#History of prior stroke and DM
#History of prior stroke and DM


== Studies Needed ==
== Studies Needed ==


#Head CT
#Head CT  
#CBC
#CBC  
#PT/PTT
#PT/PTT  
#Glu check
#Glu check  
#ECG
#ECG  
#Icon
#Icon


== tPA Administration ==
== tPA Administration ==


#Alteplase 0.9mg/kg IV (max 90mg total)
#Alteplase 0.9mg/kg IV (max 90mg total)  
##Load with .09mg/kg (10% of dose) as IV bolus over 1min, followed by 0.81mg/kg (90% of dose) as cont. infusion over 60min
##Load with .09mg/kg (10% of dose) as IV bolus over 1min, followed by 0.81mg/kg (90% of dose) as cont. infusion over 60min  
#Neuo check Q15min x 2hrs, Q30min x6hrs, Q1hr x 16hrs
#Neuo check Q15min x 2hrs, Q30min x6hrs, Q1hr x 16hrs  
#Keep BP <180/105
#Keep BP &lt;180/105  
##Labetalol 10mg IV followed by continous IV infusion 2-8mg/min OR
##Labetalol 10mg IV followed by continous IV infusion 2-8mg/min OR  
##Nicardipine IV 5mg/h, titrate up to desired effect by 2.5mg/hr q 5-15min, maximum 15mg/h
##Nicardipine IV 5mg/h, titrate up to desired effect by 2.5mg/hr q 5-15min, maximum 15mg/h  
##If BP not controlled or dia > 140 consider nitroprusside
##If BP not controlled or dia &gt; 140 consider nitroprusside  
#No anticoatulation/antiplatelets x 24hrs
#No anticoatulation/antiplatelets x 24hrs  
#Stop tPA and consider head CT if pt develops:
#Stop tPA and consider head CT if pt develops:  
##Neuro changes
##Neuro changes  
##Acute hypertension
##Acute hypertension  
##Nausea/vomiting
##Nausea/vomiting


==Complications==
== Complications ==
[[Post-tPA Hemorrhage]]


== See Also ==
[[Post-tPA Hemorrhage]]
*[[CVA (Main)]]
 
== See Also ==
 
*[[CVA (Main)]]  
*[[Post-tPA Hemorrhage]]
*[[Post-tPA Hemorrhage]]


== Source ==
== Source ==
1/26/06 DONALDSON (adapted from Lampe, Tintinali)
 
1/26/06 DONALDSON (adapted from Lampe, Tintinali)  


2/20/10 PANI (ACEP/AAN Guidelines--class B recommendations)
2/20/10 PANI (ACEP/AAN Guidelines--class B recommendations)  


AHA/ASA Guidelines
AHA/ASA Guidelines  


[[Category:Neuro]]  
[[Category:Neuro]] [[Category:Procedures]]
[[Category:Procedures]]

Revision as of 05:22, 4 August 2011

Background

  1. Pros:
    1. 30% greater chance of good neurologic outcome at 3 months
    2. Comparable 3-month mortality rate
  2. Cons
    1. Intracranial hemorrhage occurs in ~5% of pts


  • Coag results prior to tx is only required for pts on anticoagulants
  • ...but if history unable to be obtained must wait for coag results prior to starting tx

Inclusion Criteria

  1. Diagnosis of ischemic stroke causing measurable neuro deficit
  2. Clear onset (last witnessed well) <3 hours (see below for extension to <4.5 hours)
  3. Age >18 yrs

Exclusion Criteria

Absolute

  1. Head trauma or prior stroke in previous 3 months
  2. Symptoms suggestive of SAH
  3. Arterial puncture at noncompressible site in previous 7 days
  4. History of previous ICH
  5. Elevated BP (sys > 185 or dia > 110)
  6. Active bleeding on exam
  7. Acute bleeding diathesis:
    1. Plt count < 100K 
    2. PTT > upper limit of normal
    3. INR >1.7 or PT>15 sec
  8. Blood Glucose <50
  9. CT demonstrates multilobar infarction (hypodensity > 1/3 cerebral hemisphere)

Relative

  1. Minor stroke or rapidly improving stroke symptoms
  2. Seizure at onset with postictal residual neuro impairments
  3. Major surgery or serious trauma within previous 14 days
  4. Acute GI or GU hemorrhage (within previous 21 days)
  5. Acute MI (within previous 3 months)

ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours)

All the above absolute exclusion criteria apply, but now with the additional exclusion criteria below

  1. Age > 80
  2. Baseline NIHSS > 25
  3. Any oral anticoagulant use regardless of INR
  4. History of prior stroke and DM

Studies Needed

  1. Head CT
  2. CBC
  3. PT/PTT
  4. Glu check
  5. ECG
  6. Icon

tPA Administration

  1. Alteplase 0.9mg/kg IV (max 90mg total)
    1. Load with .09mg/kg (10% of dose) as IV bolus over 1min, followed by 0.81mg/kg (90% of dose) as cont. infusion over 60min
  2. Neuo check Q15min x 2hrs, Q30min x6hrs, Q1hr x 16hrs
  3. Keep BP <180/105
    1. Labetalol 10mg IV followed by continous IV infusion 2-8mg/min OR
    2. Nicardipine IV 5mg/h, titrate up to desired effect by 2.5mg/hr q 5-15min, maximum 15mg/h
    3. If BP not controlled or dia > 140 consider nitroprusside
  4. No anticoatulation/antiplatelets x 24hrs
  5. Stop tPA and consider head CT if pt develops:
    1. Neuro changes
    2. Acute hypertension
    3. Nausea/vomiting

Complications

Post-tPA Hemorrhage

See Also

Source

1/26/06 DONALDSON (adapted from Lampe, Tintinali)

2/20/10 PANI (ACEP/AAN Guidelines--class B recommendations)

AHA/ASA Guidelines